Phase I/II study of erlotinib and cci-779 (temsirolimus) for patients with recurrent malignant gliomas (nabtc 04-02) Meeting Abstract


Authors: Wen, P.; Chang, S.; Kuhn, J.; Lamborn, K.; Robins, H. I.; Yung, A.; Gilbert, M. R.; Cloughesy, T.; Lieberman, F.; De Angelis, L.; Abrey, L.; Drappatz, J.; Kesari, S.; Dancey, J.; Prados, M. D.
Abstract Title: Phase I/II study of erlotinib and cci-779 (temsirolimus) for patients with recurrent malignant gliomas (nabtc 04-02)
Meeting Title: 17th International Conference on Brain Tumor Research and Therapy (ICBTRT)
Journal Title: Neuro-Oncology
Volume: 11
Issue: 2
Meeting Dates: 2008 Jun 9-12
Meeting Location: Tokyo, Japan
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2009-04-01
Start Page: 232
Language: English
ACCESSION: ISI:000264993800077
PROVIDER: wos
DOI: 10.1215/15228517-2008-098
PMCID: PMC2718994
Notes: --- - Meeting Abstract: MTT 4 - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lauren E Abrey
    278 Abrey